Review



dok  (CancerTools Org)


Bioz Verified Symbol CancerTools Org is a verified supplier
Bioz Manufacturer Symbol CancerTools Org manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    CancerTools Org dok
    Dok, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 93/100, based on 157 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok/custom%40153251%4042383558?v=CancerTools+Org
    Average 93 stars, based on 157 article reviews
    dok - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    dok  (CancerTools Org)
    93
    CancerTools Org dok
    Dok, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok/custom%40153251%4042383558?v=CancerTools+Org
    Average 93 stars, based on 1 article reviews
    dok - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    human dysplastic oral keratinocyte dok cells  (ATCC)
    94
    ATCC human dysplastic oral keratinocyte dok cells
    Human Dysplastic Oral Keratinocyte Dok Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok/pmc12171556-50-0-53?v=ATCC
    Average 94 stars, based on 1 article reviews
    human dysplastic oral keratinocyte dok cells - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    dok je povr ina ispod roc krive za procenu rizika smrtnosti u roku od 28 dana dostigla 0 927  (Strem Chemicals)
    86
    Strem Chemicals dok je povr ina ispod roc krive za procenu rizika smrtnosti u roku od 28 dana dostigla 0 927
    Dok Je Povr Ina Ispod Roc Krive Za Procenu Rizika Smrtnosti U Roku Od 28 Dana Dostigla 0 927, supplied by Strem Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok/pm41821766-42-24-23?v=Strem+Chemicals
    Average 86 stars, based on 1 article reviews
    dok je povr ina ispod roc krive za procenu rizika smrtnosti u roku od 28 dana dostigla 0 927 - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    dok2 mouse monoclonal antibody  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology dok2 mouse monoclonal antibody
    Serum <t>anti-DOK2</t> antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Dok2 Mouse Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok/pmc12456515-154-5-11?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    dok2 mouse monoclonal antibody - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    mouse anti dok2 monoclonal antibody  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse anti dok2 monoclonal antibody
    Serum <t>anti-DOK2</t> antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Mouse Anti Dok2 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok/pmc12456515-139-8-15?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    mouse anti dok2 monoclonal antibody - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    cat 4668s rrid ab 823588 dok3 antibody f 7 santa cruz biotechnology  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology cat 4668s rrid ab 823588 dok3 antibody f 7 santa cruz biotechnology
    Serum <t>anti-DOK2</t> antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.
    Cat 4668s Rrid Ab 823588 Dok3 Antibody F 7 Santa Cruz Biotechnology, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dok/pmc12399193__mmc1-31-79-85?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    cat 4668s rrid ab 823588 dok3 antibody f 7 santa cruz biotechnology - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Journal: Hepatology Communications

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray

    doi: 10.1097/HC9.0000000000000807

    Figure Lengend Snippet: Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Article Snippet: The following antibodies were used: DOK2 mouse monoclonal antibody (clone E-10; Santa Cruz Biotechnology, Inc.), CK7 mouse monoclonal antibody (clone OV-TL 12/30; Abcam, ab68459), HepPar-1 mouse monoclonal antibody (clone OCH1E5; Santa Cruz Biotechnology, Inc.).

    Techniques: Comparison

    Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Journal: Hepatology Communications

    Article Title: Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray

    doi: 10.1097/HC9.0000000000000807

    Figure Lengend Snippet: Serum anti-DOK2 antibody levels in AIH patients following PSL treatment. (A) Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who achieved biochemical remission (left). Comparison of serum anti-DOK2 antibody levels at onset and posttreatment among AIH patients who did not achieve biochemical remission (right). p-v alues were calculated via the Wilcoxon matched-pairs signed-rank test; p <0.05 was considered significant. (B) Relationship between serum anti-DOK2 antibody and IgG levels posttreatment in patients with AIH. (C) Relationships between serum anti-DOK2 antibody levels and serum AST levels posttreatment in AIH patients. (D) Relationships between serum anti-DOK2 antibody levels and serum ALT levels posttreatment in AIH patients. p - v alues were calculated via the Wilcoxon matched-pairs signed-rank test. Abbreviations: AIH, autoimmune hepatitis; AU, arbitrary units; DOK, docking protein; PSL, prednisolone.

    Article Snippet: The tissue sections were incubated with a primary mouse anti-DOK2 monoclonal antibody (sc-17830; dilution 1:25; Santa Cruz Biotechnology Inc.) or a CD68 mouse monoclonal antibody (AT1379-1; Nichirei Bioscience Inc.) for 20 minutes at 25°C.

    Techniques: Comparison